Dynamic susceptibility contrast-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between H3-mutant and H3-wild-type high-grade midline glioma.
Child
Diffusion magnetic resonance imaging
Glioblastoma
Perfusion-weighted magnetic resonance imaging
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
18
08
2021
accepted:
21
11
2021
revised:
25
10
2021
pubmed:
14
1
2022
medline:
25
5
2022
entrez:
13
1
2022
Statut:
ppublish
Résumé
Diffuse midline gliomas, H3K27-altered (DMG-A), are malignant gliomas with an unfavorable prognosis. Knowledge of dynamic susceptibility contrast (DSC) MRI findings and imaging differences with high-grade midline glioma without H3K27 alteration (DMG-W) has been limited. We compared the DSC, ADC, and conventional MRI findings between DMG-A and DMG-W. In this single institutional retrospective study, the electronic database of our hospital between June 2015 and May 2021 was searched. Twenty and 17 patients with DMG-A (median, 13 years; range, 3-52 years; 11 females) and DMG-W (median, 40 years; 7-73 years; 9 females), respectively, were found. Normalized relative cerebral blood flow (nrCBF) and normalized corrected relative cerebral blood volume (ncrCBV); normalized maximum, mean, and minimum ADC values; and the prevalence of T2-FLAIR mismatch sign were compared between the two groups using Mann-Whitney U tests and Fisher's exact test. The nrCBF and ncrCBV were significantly lower in DMG-A compared with DMG-W (nrCBF: median 0.88 [range, 0.19-2.67] vs. 1.47 [range, 0.57-4.90] (p < 0.001); ncrCBV: 1.17 [0.20-2.67] vs. 1.56 [0.60-4.03] (p = 0.008)). Normalized maximum ADC (nADC DSC-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between DMG-A and DMG-W. • Diffuse midline glioma, H3K27-altered (DMG-A), showed a significantly lower normalized relative cerebral blood flow and volume compared with H3K27-wild-type counterparts (DMG-W). • T2-fluid-attenuated inversion recovery (FLAIR) mismatch sign was significantly more frequent in DMG-A compared to DMG-W. • Indicators that combined DSC parameters, ADC values, and T2-FLAIR mismatch sign, with or without age, are useful to distinguish the two tumors.
Identifiants
pubmed: 35022811
doi: 10.1007/s00330-021-08476-7
pii: 10.1007/s00330-021-08476-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3672-3682Informations de copyright
© 2022. The Author(s), under exclusive licence to European Society of Radiology.
Références
Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803–820
doi: 10.1007/s00401-016-1545-1
Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. https://doi.org/10.1093/neuonc/noab106
doi: 10.1093/neuonc/noab106
pubmed: 34596684
Sievers P, Sill M, Schrimpf D et al (2021) A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR. Neuro Oncol 23:34–43
doi: 10.1093/neuonc/noaa251
Cooney TM, Lubanszky E, Prasad R, Hawkins C, Mueller S (2020) Diffuse midline glioma: review of epigenetics. J Neurooncol 150:27–34
doi: 10.1007/s11060-020-03553-1
Aboian MS, Solomon DA, Felton E et al (2017) Imaging characteristics of pediatric diffuse midline gliomas with histone H3 K27M mutation. AJNR Am J Neuroradiol 38:795–800
doi: 10.3174/ajnr.A5076
Mackay A, Burford A, Carvalho D et al (2017) Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32:520-537.e5
doi: 10.1016/j.ccell.2017.08.017
Aboian MS, Tong E, Solomon DA et al (2019) Diffusion characteristics of pediatric diffuse midline gliomas with histone H3–K27M mutation using apparent diffusion coefficient histogram analysis. AJNR Am J Neuroradiol 40:1804–1810
pubmed: 31694820
pmcid: 6907069
Schulte JD, Buerki RA, Lapointe S et al (2020) Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults. Neurooncol Adv 2:vdaa142
pubmed: 33354667
pmcid: 7739048
Leach JL, Roebker J, Schafer A et al (2020) MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry. Neuro Oncol 22:1647–1657
doi: 10.1093/neuonc/noaa140
Thust S, Micallef C, Okuchi S et al (2021) Imaging characteristics of H3 K27M histone-mutant diffuse midline glioma in teenagers and adults. Quant Imaging Med Surg 11:43–56
doi: 10.21037/qims-19-954
Morana G, Tortora D, Staglianò S et al (2018) Pediatric astrocytic tumor grading: comparison between arterial spin labeling and dynamic susceptibility contrast MRI perfusion. Neuroradiology 60:437–446
doi: 10.1007/s00234-018-1992-6
Nguyen TB, Cron GO, Perdrizet K et al (2015) Comparison of the diagnostic accuracy of DSC- and dynamic contrast-enhanced MRI in the preoperative grading of astrocytomas. AJNR Am J Neuroradiol 36:2017–2022
doi: 10.3174/ajnr.A4398
Löbel U, Sedlacik J, Reddick WE et al (2011) Quantitative diffusion-weighted and dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging analysis of T2 hypointense lesion components in pediatric diffuse intrinsic pontine glioma. AJNR Am J Neuroradiol 32:315–322
doi: 10.3174/ajnr.A2277
Sedlacik J, Winchell A, Kocak M, Loeffler RB, Broniscer A, Hillenbrand CM (2013) MR imaging assessment of tumor perfusion and 3D segmented volume at baseline, during treatment, and at tumor progression in children with newly diagnosed diffuse intrinsic pontine glioma. AJNR Am J Neuroradiol 34:1450–1455
doi: 10.3174/ajnr.A3421
Patel SH, Poisson LM, Brat DJ et al (2017) T2-FLAIR mismatch, an imaging biomarker for IDH and 1p/19q status in lower-grade gliomas: a TCGA/TCIA project. Clin Cancer Res 23:6078–6085
doi: 10.1158/1078-0432.CCR-17-0560
Juratli TA, Tummala SS, Riedl A et al (2019) Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups. J Neurooncol 141:327–335
doi: 10.1007/s11060-018-03034-6
Chen H, Hu W, He H, Yang Y, Wen G, Lv X (2019) Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurements. Eur J Radiol 114:152–159
doi: 10.1016/j.ejrad.2019.03.006
Mouridsen K, Christensen S, Gyldensted L, Ostergaard L (2006) Automatic selection of arterial input function using cluster analysis. Magn Reson Med 55:524–531
doi: 10.1002/mrm.20759
Meyronet D, Esteban-Mader M, Bonnet C et al (2017) Characteristics of H3 K27M-mutant gliomas in adults. Neuro Oncol 19:1127–1134
doi: 10.1093/neuonc/now274
Ebrahimi A, Skardelly M, Schuhmann MU et al (2019) High frequency of H3 K27M mutations in adult midline gliomas. J Cancer Res Clin Oncol 145:839–850
doi: 10.1007/s00432-018-02836-5
Schreck KC, Ranjan S, Skorupan N et al (2019) Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas. J Neurooncol 143:87–93
doi: 10.1007/s11060-019-03134-x
Chi AS, Tarapore RS, Hall MD et al (2019) Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201. J Neurooncol 145:97–105
doi: 10.1007/s11060-019-03271-3
Broen MPG, Smits M, Wijnenga MMJ et al (2018) The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study. Neuro Oncol 20:1393–1399
doi: 10.1093/neuonc/noy048
Fujita Y, Nagashima H, Tanaka K et al (2021) The histopathologic and radiologic features of T2-FLAIR mismatch sign in IDH-Mutant 1p/19q non-codeleted astrocytomas. World Neurosurg 149:e253–e260
doi: 10.1016/j.wneu.2021.02.042
Deguchi S, Oishi T, Mitsuya K et al (2020) Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas. Sci Rep 10:10113
doi: 10.1038/s41598-020-67244-7
Aliotta E, Dutta SW, Feng X et al (2020) Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch sign. J Neurooncol 149:325–335
doi: 10.1007/s11060-020-03611-8
Onishi S, Amatya VJ, Kolakshyapati M et al (2020) T2-FLAIR mismatch sign in dysembryoplasticneuroepithelial tumor. Eur J Radiol 126:108924
doi: 10.1016/j.ejrad.2020.108924
Johnson DR, Kaufmann TJ, Patel SH, Chi AS, Snuderl M, Jain R (2019) There is an exception to every rule-T2-FLAIR mismatch sign in gliomas. Neuroradiology 61:225–227
doi: 10.1007/s00234-018-2148-4
Draaisma K, Wijnenga MM, Weenink B et al (2015) PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients. Acta Neuropathol Commun 3:88
doi: 10.1186/s40478-015-0265-4
Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M (1986) MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 161:401–407
doi: 10.1148/radiology.161.2.3763909
Harshbarger TB, Song AW (2006) Endogenous functional CBV contrast revealed by diffusion weighting. NMR Biomed 19:1020–1027
doi: 10.1002/nbm.1067